Necrotizing Enterocolitis of Newborn
16
1
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
88.9%
+2.4% vs benchmark
25%
4 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
NICU Antibiotics and Outcomes Trial
Single Vs Multi-strain Probiotics for Preterm Neonates
Role of Probiotic Use in Outcomes of Premature Birth
Amniotic Fluid & the Preterm Gut
CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis
Necrotizing Enterocolities
Impact of Enteral Feeding on Splanchnic Oxygenation During Packed Red Blood Cell Transfusion in Preterm Infants
Does Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding?
The Intestinal Dysbacteriosis in the Pathogenesis of Necrotizing Enterocolitis
Probiotics/TPN in the NICU
Risk Factors of Necrotizing Enterocolitis in Premature Newborns
Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial
The Relationship Between Erythrocyte Transfusion and Nutrition and Necrotizing Enterocolitis in Preterm Infants
Monitoring of Systemic or Organ Perfusion for Preterm Infants
The Effect of β-Carotene, Vitamin D3 and Zinc on Hyaline Membrane Disease and Feeding Intolerance in Premature Neonates